Source: PharmaTech

I D A: Chiltern Acquires Japanese CRO

Chiltern has acquired Integrated Development Associates (IDA), a Japanese CRO specializing in integrating Japan and Asia into global drug development. Under this acquisition, IDA will do business as a subsidiary of Chiltern and be renamed IDA, a Chiltern Company. Read the full release he

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
John Winebarger's photo - President & CEO of I D A

President & CEO

John Winebarger

CEO Approval Rating

70/100

Read more